Protection of crystal-induced polymorphonuclear leukocyte membranolysis by phosphocitrate.
The protection afforded by phosphocitrate, a phosphorylated polycarboxylic acid, against crystal-induced membrane damage to polymorphonuclear leukocytes was studied in vitro. Membranolysis was assessed by nitro blue tetrazolium salt reduction, lactate dehydrogenase release, and scanning electron microscopy. Phosphocitrate protected strongly against hydroxyapatite crystal-induced damage, an action attributable to crystal surface binding of phosphocitrate rather than to the membrane. The ability of phosphocitrate to prevent hydroxyapatite crystallization, together with its membrane protective effect against preformed crystals, would suggest that the compound might have a useful future role against crystal-induced arthropathies.
Sallis
J D
JD
Biochemistry Department, University of Tasmania, Hobart, Australia.
Shankar
R
R
Rees
B
B
Thomson
R
R
D001031:Apatites / Q000037:antagonists & inhibitors / Q000633:toxicity*; D002131:Calcium Pyrophosphate / Q000037:antagonists & inhibitors / Q000633:toxicity*; D002462:Cell Membrane / Q000187:drug effects / Q000648:ultrastructure; D002951:Citrates / Q000494:pharmacology*; D011756:Diphosphates / Q000633:toxicity*; D006801:Humans; D008854:Microscopy, Electron; D009504:Neutrophils / Q000187:drug effects* / Q000648:ultrastructure
D001031:Apatites; D002951:Citrates; D011756:Diphosphates; C014148:phosphocitrate; D002131:Calcium Pyrophosphate